LRRK2基因与帕金森病

被引：8

作者：

刘鹏

秦川

机构：

[1] 中国医学科学院实验动物研究所北京协和医学院比较医学中心卫生部人类疾病比较医学重点实验室

来源：

中国比较医学杂志 | 2008年 / 08期

关键词：

帕金森; 基因,LRRK2; dardarin;

D O I：

暂无

中图分类号：

R742.5 [震颤麻痹综合征];

学科分类号：

100204 [神经病学];

摘要：

帕金森病是一种复杂的多因素共同作用的神经变性性疾病,遗传因素和环境因素被认为是发病的重要原因。越来越多的研究发现遗传因素在其发病中起着重要作用,而最近LRRK2基因的发现更加确定了遗传因素在帕金森发病中不可忽视的作用。本文对LRRK2基因以及LRRK2基因在帕金森病中的研究做一综述。

引用

页码：40 / 43+52 +52

页数：5

共 10 条

[1]

The Parkinson's disease-associated protein, leucine-rich repeat kinase 2 (LRRK2), is an authentic GTPase that stimulates kinase activity [J].

Guo, Luxuan ;

Gandhi, Payal N. ;

Wang, Wen ;

Petersen, Robert B. ;

Wilson-Delfosse, Amy L. ;

Chen, Shu G. .

EXPERIMENTAL CELL RESEARCH, 2007, 313 (16) :3658-3670

[2]

Evaluation of LRRK2 G2019S penetrance -: Relevance for genetic counseling in Parkinson disease [J].

Goldwurm, S. ;

Zini, M. ;

Mariani, L. ;

Tesei, S. ;

Miceli, R. ;

Sironi, F. ;

Clementi, M. ;

Bonifati, V. ;

Pezzoli, G. .

NEUROLOGY, 2007, 68 (14) :1141-1143

[3]

LRRK2 protein is a component of Lewy bodies [J].

Zhu, Xiongwei ;

Siedlak, Sandra L. ;

Smith, Mark A. ;

Perry, George ;

Chen, Shu G. .

ANNALS OF NEUROLOGY, 2006, 60 (05) :617-618

[4]

The LRRK2 Gly2385Arg variant is associated with Parkinson's disease:: genetic and functional evidence [J].

Tan, E. K. ;

Zhao, Y. ;

Skipper, L. ;

Tan, M. G. ;

Di Fonzo, A. ;

Sun, L. ;

Fook-Chong, S. ;

Tang, S. ;

Chua, E. ;

Yuen, Y. ;

Tan, L. ;

Pavanni, R. ;

Wong, M. C. ;

Kolatkar, P. ;

Lu, C. S. ;

Bonifati, V. ;

Liu, J. J. .

HUMAN GENETICS, 2007, 120 (06) :857-863

[5]

The LRRK2 I2012T, G2019S and I2020T mutations are not common in patients with essential tremor [J].

Deng, Hao ;

Le, WeiDong ;

Davidson, Anthony L. ;

Xie, WenJie ;

Jankovic, Joseph .

NEUROSCIENCE LETTERS, 2006, 407 (02) :97-100

[6]

The familial parkinsonism gene LRRK2 regulates neurite process morphology [J].

MacLeod, David ;

Dowman, Julia ;

Hammond, Rachel ;

Leete, Thomas ;

Inoue, Keiichi ;

Abeliovich, Asa .

NEURON, 2006, 52 (04) :587-593

[7]

Biochemical and pathological characterization of Lrrk2 [J].

Giasson, BI ;

Covy, JP ;

Bonini, NM ;

Hurtig, HI ;

Farrer, MJ ;

Trojanowski, JQ ;

Van Deerlin, VM .

ANNALS OF NEUROLOGY, 2006, 59 (02) :315-322

[8]

A common LRRK2 mutation in idiopathic Parkinson's disease.[J].William P Gilks;Patrick M Abou-Sleiman;Sonia Gandhi;Shushant Jain;Andrew Singleton;Andrew J Lees;Karen Shaw;Kailash P Bhatia;Vincenzo Bonifati;Niall P Quinn;John Lynch;Daniel G Healy;Janice L Holton;Tamas Revesz;Nicholas W Wood.The Lancet.2005, 9457

[9]

Identification of a novel LRRK2 mutation linked to autosomal dominant parkinsonism:: Evidence of a common founder across European populations [J].

Kachergus, J ;

Mata, IF ;

Hulihan, M ;

Taylor, JP ;

Lincoln, S ;

Aasly, J ;

Gibson, JM ;

Ross, OA ;

Lynch, T ;

Wiley, J ;

Payami, H ;

Nutt, J ;

Maraganore, DM ;

Czyzewski, K ;

Styczynska, M ;

Wszolek, ZK ;

Farrer, MJ ;

Toft, M .

AMERICAN JOURNAL OF HUMAN GENETICS, 2005, 76 (04) :672-680

[10]

Mutations in LRRK2 cause autosomal-dominant Parkinsonism with pleomorphic pathology [J].

Zimprich, A ;

Biskup, S ;

Leitner, P ;

Lichtner, P ;

Farrer, M ;

Lincoln, S ;

Kachergus, J ;

Hulihan, M ;

Uitti, RJ ;

Calne, DB ;

Stoessl, AJ ;

Pfeiffer, RF ;

Patenge, N ;

Carbajal, IC ;

Vieregge, P ;

Asmus, F ;

Müller-Myhsok, B ;

Dickson, DW ;

Meitinger, T ;

Strom, TM ;

Wszolek, ZK ;

Gasser, T .

NEURON, 2004, 44 (04) :601-607

← 1 →